Casa
scp 666 1/2 j

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Full article: At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The Endocannabinoid System. Calcium channels are opened by postsynaptic
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma - ScienceDirect
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Pharmacognosy and Effects of Cannabinoids in the Vascular System
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma - ScienceDirect
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
CB₂R ligands to treat inflammatory diseases
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The endocannabinoid system and its therapeutic exploitation
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Understanding the Magic of the Endocannabinoid System – Hempy Longstocking
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The endocannabinoid system and its therapeutic exploitation
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
de por adulto (o preço varia de acordo com o tamanho do grupo)